Montgomery's Rehab Arc Tightens Rangers' Rotation Window

Jordan Montgomery threw two innings for Triple-A Round Rock on Thursday, yielding two runs on three hits with three strikeouts and no walks across 39 pitches. The performance itself—clean mechanics, strike efficiency at 67%—matters less than what it signals: the Rangers are closing in on a second-half rotation reinforcement that could reshape their playoff odds. Montgomery inked a one-year deal with Texas during spring training while still ramping from Tommy John surgery. The team gambled that he'd be available for the pennant push. That bet is about to pay off.

Texas has spent the past month functioning as a rotation-by-committee outfit. Jack Leiter landed on the injured list following ankle surgery; Chris Paddack made one emergency start last week before getting designated for assignment. The Rangers have been duct-taping holes with marginal depth, the kind of stop-gap pitching that costs teams 2-3 games down the stretch. Montgomery's return—likely shortly after the All-Star break—plugs that leak and gives the Rangers a front-line arm they paid for upfront. Manager Skip Schumaker's tone in his updates shifted noticeably: no longer managing injury uncertainty, he's tracking a progression without setbacks.

Cody Bradford, Texas's other elbow-surgery reclamation project, threw live batting practice on Thursday, working all four pitches for strikes across one simulated inning. Bradford still needs one more live session before a rehab assignment; Montgomery is one step ahead. The sequencing matters. Two proven starters returning within a window of weeks fundamentally alters how the Rangers can construct their September rotation and playoff bullpen depth. A staff that looked fragile in June becomes durable in October.

For bettors, this reshapes Rangers run-line and team total equity over the next 10-14 days—the window before both arms are back online. Right now, with the rotation in crisis mode, Texas is getting underlaid in games where its remaining starters face competent offenses. Once Montgomery starts making major-league appearances, the live pricing won't account for the actual quality delta fast enough. The Rangers' next 15 games are a bridge phase where the market hasn't repriced for depth that's about to arrive. Fade their team totals until Montgomery's rehab path clarifies; once he's assigned to a final start, the gap between what oddsmakers have priced and what the rotation can actually deliver widens considerably.